Publication | Open Access
A phase Ib study of pembrolizumab following trans-arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): PETAL
27
Citations
0
References
2019
Year
Phase Ib StudyHepatologyMedicinePharmacologyPathologyLiver CancerCancer TreatmentOncologyRadiation OncologyHepatocellular CarcinomaTrans-arterial Chemoembolization
No additional data available for this publication yet. Check back later!